Cordycepin reduced the expression of the EMT factors in 72 melanoma patient samples comprising HMGA2, Twist1, and ZEB1, and the inhibition of HMGA2 sensitized gastric cancer cells to chemotherapy treatment [178, 179]. Here, TWIST1 is linked to melanoma.